Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3546388)

Published in Histopathology on August 08, 2012

Authors

Massimo Mascolo1, Gennaro Ilardi, Maria Fiammetta Romano, Angela Celetti, Maria Siano, Simona Romano, Chiara Luise, Francesco Merolla, Alba Rocco, Maria Luisa Vecchione, Gaetano De Rosa, Stefania Staibano

Author Affiliations

1: Department of Biomorphological and Functional Sciences, Pathology Section, School of Medicine, University 'Federico II', Naples, Italy.

Articles cited by this

The measurement of observer agreement for categorical data. Biometrics (1977) 216.56

Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28

Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell (2009) 12.96

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell (2010) 11.20

Primary bioassay of human tumor stem cells. Science (1977) 9.69

Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J (1999) 9.00

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70

A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A (2004) 6.84

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell (2009) 6.77

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46

CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature (2009) 4.83

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A (2009) 4.19

E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res (1996) 4.14

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol (2009) 3.70

Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol (2008) 3.55

Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci (1998) 2.78

Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer (2010) 2.69

Phase I study of the poly(ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res (2008) 2.56

Chromatin assembly factor 1 is essential and couples chromatin assembly to DNA replication in vivo. Proc Natl Acad Sci U S A (2003) 2.36

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int J Cancer (2009) 2.33

Observer variation in immunohistochemical analysis of protein expression, time for a change? Histopathology (2006) 2.14

The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell Biol (2005) 2.14

Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst (2006) 2.10

Cancer stem cells: problems for therapy? J Pathol (2010) 1.83

CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clin Cancer Res (2009) 1.72

Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70

The natural history of human papillomavirus infections of the mucosal epithelia. APMIS (2010) 1.61

Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res (2001) 1.60

Understanding the cancer stem cell. Br J Cancer (2010) 1.42

Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci (2004) 1.42

Cancer stem cells and their niche. Cancer Sci (2009) 1.39

Silencing of chromatin assembly factor 1 in human cells leads to cell death and loss of chromatin assembly during DNA synthesis. Mol Cell Biol (2004) 1.38

Modulating poly (ADP-ribose) polymerase activity: potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr Pharm Biotechnol (2002) 1.35

p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer (2010) 1.34

Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer (2010) 1.33

"High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol (2000) 1.33

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Free Radic Biol Med (2009) 1.33

Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33

Cancer stem cells in head and neck squamous cell carcinoma. J Oncol (2010) 1.31

Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol (2010) 1.29

Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death Differ (2010) 1.26

Chromatin assembly factors Asf1 and CAF-1 have overlapping roles in deactivating the DNA damage checkpoint when DNA repair is complete. Proc Natl Acad Sci U S A (2009) 1.25

Inhibition of poly(ADP-ribose) polymerase in cancer. Curr Opin Pharmacol (2006) 1.20

Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol (2005) 1.20

Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res (1998) 1.18

Human papillomavirus genotyping using archival vulval dysplastic or neoplastic biopsy tissues: comparison between the INNO-LiPA and linear array assays. J Clin Microbiol (2010) 1.18

Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. Hum Pathol (2005) 1.13

Chromatin assembly factor-1, a marker of clinical value to distinguish quiescent from proliferating cells. Cancer Res (2004) 1.13

Essential role of chromatin assembly factor-1-mediated rapid nucleosome assembly for DNA replication and cell division in vertebrate cells. Mol Biol Cell (2006) 1.12

How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat Rev (2009) 1.10

Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Clin Cancer Res (2005) 1.09

Synthesis of DNA and poly(adenosine diphosphate ribose) in normal and chronic lymphocytic leukemia lymphocytes. J Clin Invest (1978) 1.07

CAF-I-dependent control of degradation of the discontinuous strands during mismatch repair. Proc Natl Acad Sci U S A (2011) 1.05

Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma. Oral Dis (2006) 1.05

A tumour stem cell hypothesis for the origins of prostate cancer. BJU Int (2005) 1.04

HPV and its effect on head and neck cancer prognosis. Clin Adv Hematol Oncol (2010) 1.04

The emerging role of poly(ADP-ribose) polymerase-1 in longevity. Int J Biochem Cell Biol (2004) 1.03

Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. Expert Opin Med Diagn (2010) 1.03

Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers. Int J Radiat Oncol Biol Phys (2009) 1.02

Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Cancer (1983) 1.01

Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2003) 1.01

Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome. Int J Gynecol Pathol (2007) 1.00

Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Head Neck (2010) 0.99

Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J Clin Microbiol (2008) 0.99

New targets for cancer chemotherapy--poly(ADP-ribosylation) processing and polyisoprene metabolism. Biol Rev Camb Philos Soc (1990) 0.98

Chromatin reassembly signals the end of DNA repair. Cell Cycle (2008) 0.97

Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency. J Invest Dermatol (2002) 0.97

Cancer stem cell immunophenotypes in oral squamous cell carcinoma. J Oral Pathol Med (2010) 0.96

HPV and prognosis for patients with oropharynx cancer. Eur J Cancer (2009) 0.96

Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer (2004) 0.95

Aberration of poly(adenosine diphosphate-ribose) metabolism in human colon adenomatous polyps and cancers. Cancer Res (1983) 0.94

Potential for therapeutic targeting of tumor stem cells. Cancer Sci (2009) 0.94

Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. Int J Oral Maxillofac Surg (2006) 0.93

Molecular mechanisms of head and neck cancer. Expert Rev Anticancer Ther (2008) 0.91

Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours. Histopathology (2010) 0.90

p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol (2009) 0.89

Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer. Histopathology (2009) 0.89

Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology (2007) 0.89

Poly(ADP-ribose) synthesis in human cervical cancer cell-diagnostic cytological usefulness. Cancer Lett (1981) 0.89

Differential expression of HIF-1α in CD44+CD24-/low breast ductal carcinomas. Diagn Pathol (2011) 0.87

A simple and economical method for the manual construction of well-aligned tissue arrays. Pathol Res Pract (2006) 0.87

The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: proposal of a concept. J Oral Pathol Med (2008) 0.85

Poly(ADP-ribose) polymerase in DNA damage-response pathway: implications for radiation oncology. Int J Cancer (2000) 0.84

Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain. J Neural Transm Suppl (2003) 0.83

The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours. Oncol Rep (2011) 0.81

Cancer stem cell model in oral squamous cell carcinoma. Curr Stem Cell Res Ther (2008) 0.81

MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea. Br J Cancer (2009) 0.80

Real time investigation of protein folding, structure, and dynamics in living cells. Methods Cell Biol (2008) 0.79

Chemotherapy strategies in squamous cell carcinoma of the head and neck. Crit Rev Oncol Hematol (1984) 0.79

Successful treatment of extensive human papillomavirus-associated oral leucoplakia with imiquimod. Br J Dermatol (2007) 0.78

Articles by these authors

Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18

Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol (2003) 4.15

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut (2010) 2.79

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature (2007) 2.54

BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma. J Clin Oncol (2012) 2.41

Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci U S A (2003) 2.39

Melanoma simulating seborrheic keratosis: a major dermoscopy pitfall. Arch Dermatol (2003) 2.24

Long-term perimetric fluctuation in patients with different stages of glaucoma. Br J Ophthalmol (2010) 2.02

Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. Clin Cancer Res (2002) 2.01

Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle (2010) 1.73

MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells. Lab Invest (2012) 1.56

Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood (2005) 1.50

Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology (2012) 1.47

Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases. Curr Med Chem (2014) 1.37

The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol (2005) 1.36

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol (2007) 1.25

Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression. Carcinogenesis (2007) 1.24

Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol (2003) 1.22

Akt activation correlates with adverse outcome in tongue cancer. Cancer (2005) 1.20

Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Carcinogenesis (2005) 1.18

Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17

Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. J Clin Endocrinol Metab (2005) 1.17

In vivo characterisation of superficial colorectal neoplastic lesions with high-resolution probe-based confocal laser endomicroscopy in combination with video-mosaicing: a feasibility study to enhance routine endoscopy. Dig Liver Dis (2010) 1.16

Accuracy in melanoma detection: a 10-year multicenter survey. J Am Acad Dermatol (2011) 1.15

Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. Hum Pathol (2005) 1.13

Prognostic significance of multidrug-resistance protein (MDR-1) in renal clear cell carcinomas: a five year follow-up analysis. BMC Cancer (2006) 1.13

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate (2006) 1.12

Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells. Eur J Cancer (2004) 1.12

Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells. Int J Cancer (2013) 1.10

Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Clin Cancer Res (2005) 1.09

Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. J Med Case Rep (2012) 1.09

Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2004) 1.08

Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc Natl Acad Sci U S A (2005) 1.07

Physical activity and sports participation in children and adolescents with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis (2006) 1.07

Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. J Pathol (2004) 1.06

Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest (2010) 1.06

Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology (2007) 1.05

Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer (2007) 1.05

FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. Cardiovasc Res (2008) 1.05

BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther (2003) 1.04

Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions: an interdisciplinary study on 107 cases. Cancer (2002) 1.04

The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinology (2006) 1.02

Rapamycin antagonizes NF-kappaB nuclear translocation activated by TNF-alpha in primary vascular smooth muscle cells and enhances apoptosis. Am J Physiol Heart Circ Physiol (2006) 1.01

H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization. Oncogene (2004) 1.01

Dermoscopy Pattern, Histopathology and Immunophenotype of Primary Cutaneous B-Cell Lymphoma Presenting as a Solitary Skin Nodule. Dermatology (2015) 1.00

Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis. J Cell Physiol (2011) 0.99

Chlamydia psittaci in ocular adnexa MALT lymphoma: a possible role in lymphomagenesis and a different geographical distribution. Infect Agent Cancer (2012) 0.98

Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter (2005) 0.98

Helicobacter pylori Hp(2-20) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo. J Immunol (2009) 0.97

Ovarian luteinized thecoma with sclerosing peritonitis in an adult woman treated with leuprolide and toremifene in complete remission at 5 years. Gynecol Oncol (2005) 0.97

Spectral-domain optical coherence tomography findings in pediatric tilted disc syndrome. Graefes Arch Clin Exp Ophthalmol (2014) 0.97

p66Shc deletion confers vascular protection in advanced atherosclerosis in hypercholesterolemic apolipoprotein E knockout mice. Endothelium (2008) 0.96

Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis. Adv Ther (2010) 0.96

Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. J Immunol (2006) 0.96

In-vivo characterization of DALM in ulcerative colitis with high-resolution probe-based confocal laser endomicroscopy. World J Gastroenterol (2011) 0.95

FK506 binding proteins as targets in anticancer therapy. Anticancer Agents Med Chem (2010) 0.95

Diagnostic accuracy of confocal laser endomicroscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis. World J Gastrointest Endosc (2012) 0.95

BAG3 protein delocalisation in prostate carcinoma. Tumour Biol (2010) 0.94

Renal metastasis from thyroid carcinoma 35 years after detection of the primary tumor. Tumori (2003) 0.92

Molecular expression of Gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastric lesions. Cancer Biol Ther (2008) 0.92

Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells. Oncogene (2004) 0.92

Pirin inhibits cellular senescence in melanocytic cells. Am J Pathol (2011) 0.92

Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis (2011) 0.92

CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol Immunother (2007) 0.91

Epigenetic disregulation in oral cancer. Int J Mol Sci (2012) 0.91

Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx. BMC Cancer (2006) 0.91

HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol (2004) 0.90

Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. BMC Cancer (2010) 0.90